• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of transbhomepageaboutsubmitalertseditorial board
Philos Trans R Soc Lond B Biol Sci. Jun 29, 2004; 359(1446): 857–871.
PMCID: PMC1693382

Metabolic profiles to define the genome: can we hear the phenotypes?

Abstract

There is an increased reliance on genetically modified organisms as a functional genomic tool to elucidate the role of genes and their protein products. Despite this, many models do not express the expected phenotype thought to be associated with the gene or protein. There is thus an increased need to further define the phenotype resultant from a genetic modification to understand how the transcriptional or proteomic network may conspire to alter the expected phenotype. This is best typified by the description of the silent phenotype in genetic manipulations of yeast. High-resolution proton nuclear magnetic resonance ((1)H NMR) spectroscopy provides an ideal mechanism for the profiling of metabolites within biofluids, tissue extracts or, with recent advances, intact tissues. These metabolic datasets can be readily mined using a range of pattern recognition techniques, including hierarchical cluster analysis, principal components analysis, partial least squares and neural networks, with the combined approach being termed metabolomics. This review describes the application of NMR-based metabolomics or metabonomics to genetic and chemical interventions in a number of different species, demonstrating the versatility of such an approach, as well as suggesting how it may be integrated with other "omic" technologies.

Full Text

The Full Text of this article is available as a PDF (889K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Allen Jess, Davey Hazel M, Broadhurst David, Heald Jim K, Rowland Jem J, Oliver Stephen G, Kell Douglas B. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol. 2003 Jun;21(6):692–696. [PubMed]
  • Anderson JL, Head SI, Rae C, Morley JW. Brain function in Duchenne muscular dystrophy. Brain. 2002 Jan;125(Pt 1):4–13. [PubMed]
  • Bailey NJ, Cooper P, Hadfield ST, Lenz EM, Lindon JC, Nicholson JK, Stanley PD, Wilson ID, Wright B, Taylor SD. Application of directly coupled HPLC-NMR-MS/MS to the identification of metabolites of 5-trifluoromethylpyridone (2-hydroxy-5-trifluoromethylpyridine) in hydroponically grown plants. J Agric Food Chem. 2000 Jan;48(1):42–46. [PubMed]
  • Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest. 1999 Aug;104(4):375–381. [PMC free article] [PubMed]
  • Beckwith-Hall BM, Nicholson JK, Nicholls AW, Foxall PJ, Lindon JC, Connor SC, Abdi M, Connelly J, Holmes E. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Toxicol. 1998 Apr;11(4):260–272. [PubMed]
  • Bochner BR, Gadzinski P, Panomitros E. Phenotype microarrays for high-throughput phenotypic testing and assay of gene function. Genome Res. 2001 Jul;11(7):1246–1255. [PMC free article] [PubMed]
  • Bollard ME, Garrod S, Holmes E, Lindon JC, Humpfer E, Spraul M, Nicholson JK. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn Reson Med. 2000 Aug;44(2):201–207. [PubMed]
  • Brindle Joanne T, Antti Henrik, Holmes Elaine, Tranter George, Nicholson Jeremy K, Bethell Hugh W L, Clarke Sarah, Schofield Peter M, McKilligin Elaine, Mosedale David E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002 Dec;8(12):1439–1444. [PubMed]
  • Buchholz Arne, Hurlebaus Jochen, Wandrey Christian, Takors Ralf. Metabolomics: quantification of intracellular metabolite dynamics. Biomol Eng. 2002 Jun;19(1):5–15. [PubMed]
  • Bundy Jacob G, Spurgeon David J, Svendsen Claus, Hankard Peter K, Osborn Daniel, Lindon John C, Nicholson Jeremy K. Earthworm species of the genus Eisenia can be phenotypically differentiated by metabolic profiling. FEBS Lett. 2002 Jun 19;521(1-3):115–120. [PubMed]
  • Burton Edward A, Davies Kay E. Muscular dystrophy--reason for optimism? Cell. 2002 Jan 11;108(1):5–8. [PubMed]
  • Carmichael PL. Mechanisms of action of antiestrogens: relevance to clinical benefits and risks. Cancer Invest. 1998;16(8):604–611. [PubMed]
  • Castrillo Juan I, Hayes Andrew, Mohammed Shabaz, Gaskell Simon J, Oliver Stephen G. An optimized protocol for metabolome analysis in yeast using direct infusion electrospray mass spectrometry. Phytochemistry. 2003 Mar;62(6):929–937. [PubMed]
  • Cemal Cemal K, Carroll Christopher J, Lawrence Lorraine, Lowrie Margaret B, Ruddle Piers, Al-Mahdawi Sahar, King Rosalind H M, Pook Mark A, Huxley Clare, Chamberlain Susan. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum Mol Genet. 2002 May 1;11(9):1075–1094. [PubMed]
  • Cordier L, Hack AA, Scott MO, Barton-Davis ER, Gao G, Wilson JM, McNally EM, Sweeney HL. Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. Mol Ther. 2000 Feb;1(2):119–129. [PubMed]
  • Dawson G, Cho S. Batten's disease: clues to neuronal protein catabolism in lysosomes. J Neurosci Res. 2000 Apr 15;60(2):133–140. [PubMed]
  • De Luca V, St Pierre B. The cell and developmental biology of alkaloid biosynthesis. Trends Plant Sci. 2000 Apr;5(4):168–173. [PubMed]
  • Devaux PG, Horning MG, Hill RM, Horning EC. O-benzyloximes: derivatives for the study of ketosteroids by gas chromatography. Application to urinary steroids of the newborn human. Anal Biochem. 1971 May;41(1):70–82. [PubMed]
  • Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, Chneiweiss H, Benomar A, Lyon-Caen O, Julien J, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol. 1996 Apr;39(4):490–499. [PubMed]
  • Evans GA. Designer science and the "omic" revolution. Nat Biotechnol. 2000 Feb;18(2):127–127. [PubMed]
  • Even PC, Decrouy A, Chinet A. Defective regulation of energy metabolism in mdx-mouse skeletal muscles. Biochem J. 1994 Dec 1;304(Pt 2):649–654. [PMC free article] [PubMed]
  • Evert BO, Wüllner U, Klockgether T. Cell death in polyglutamine diseases. Cell Tissue Res. 2000 Jul;301(1):189–204. [PubMed]
  • Fiehn Oliver. Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol. 2002 Jan;48(1-2):155–171. [PubMed]
  • Fiehn Oliver. Metabolic networks of Cucurbita maxima phloem. Phytochemistry. 2003 Mar;62(6):875–886. [PubMed]
  • Fiehn O, Kopka J, Dörmann P, Altmann T, Trethewey RN, Willmitzer L. Metabolite profiling for plant functional genomics. Nat Biotechnol. 2000 Nov;18(11):1157–1161. [PubMed]
  • Florian CL, Preece NE, Bhakoo KK, Williams SR, Noble M. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed. 1995 Sep;8(6):253–264. [PubMed]
  • Florian CL, Preece NE, Bhakoo KK, Williams SR, Noble MD. Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. Cancer Res. 1995 Jan 15;55(2):420–427. [PubMed]
  • Garrod S, Humpher E, Connor SC, Connelly JC, Spraul M, Nicholson JK, Holmes E. High-resolution (1)H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn Reson Med. 2001 May;45(5):781–790. [PubMed]
  • Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett. 2000 Nov 10;484(3):169–174. [PubMed]
  • Gieseler K, Grisoni K, Ségalat L. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans. Curr Biol. 2000 Sep 21;10(18):1092–1097. [PubMed]
  • Gillet B, Doan BT, Verre-Serrie C, Barbere B, Berenger G, Morin S, Koenig J, Peres M, Sebille A, Beloeil JC. In vivo 2D 1H NMR of mdx mouse muscle and myoblast cells during fusion: evidence for a characteristic signal of long chain fatty acids. Neuromuscul Disord. 1993 Sep-Nov;3(5-6):433–438. [PubMed]
  • Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H, Galibert F, Hoheisel JD, Jacq C, Johnston M, et al. Life with 6000 genes. Science. 1996 Oct 25;274(5287):546–567. [PubMed]
  • Goodacre R, Shann B, Gilbert RJ, Timmins EM, McGovern AC, Alsberg BK, Kell DB, Logan NA. Detection of the dipicolinic acid biomarker in Bacillus spores using Curie-point pyrolysis mass spectrometry and Fourier transform infrared spectroscopy. Anal Chem. 2000 Jan 1;72(1):119–127. [PubMed]
  • Griffin JL, Walker LA, Garrod S, Holmes E, Shore RF, Nicholson JK. NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat. Comp Biochem Physiol B Biochem Mol Biol. 2000 Nov;127(3):357–367. [PubMed]
  • Griffin JL, Walker LA, Troke J, Osborn D, Shore RF, Nicholson JK. The initial pathogenesis of cadmium induced renal toxicity. FEBS Lett. 2000 Jul 28;478(1-2):147–150. [PubMed]
  • Griffin JL, Williams HJ, Sang E, Clarke K, Rae C, Nicholson JK. Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem. 2001 Jun 1;293(1):16–21. [PubMed]
  • Griffin JL, Walker LA, Shore RF, Nicholson JK. Metabolic profiling of chronic cadmium exposure in the rat. Chem Res Toxicol. 2001 Oct;14(10):1428–1434. [PubMed]
  • Griffin JL, Walker L, Shore RF, Nicholson JK. High-resolution magic angle spinning 1H-NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity. Xenobiotica. 2001 Jun;31(6):377–385. [PubMed]
  • Griffin JL, Williams HJ, Sang E, Nicholson JK. Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning (1)H NMR spectroscopy. Magn Reson Med. 2001 Aug;46(2):249–255. [PubMed]
  • Griffin JL, Sang E, Evens T, Davies K, Clarke K. Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy. FEBS Lett. 2002 Oct 23;530(1-3):109–116. [PubMed]
  • Griffin JL, Muller D, Woograsingh R, Jowatt V, Hindmarsh A, Nicholson JK, Martin JE. Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics. Physiol Genomics. 2002 Dec 3;11(3):195–203. [PubMed]
  • Griffin Julian L, Bollard Mary, Nicholson Jeremy K, Bhakoo Kishore. Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed. 2002 Oct;15(6):375–384. [PubMed]
  • Griffin JL, Pole JCM, Nicholson JK, Carmichael PL. Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy. Biochim Biophys Acta. 2003 Jan 20;1619(2):151–158. [PubMed]
  • Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999 Sep 23;401(6751):390–394. [PubMed]
  • Hall Robert, Beale Mike, Fiehn Oliver, Hardy Nigel, Sumner Lloyd, Bino Raoul. Plant metabolomics: the missing link in functional genomics strategies. Plant Cell. 2002 Jul;14(7):1437–1440. [PMC free article] [PubMed]
  • Hoffman EP, Beggs AH, Koenig M, Kunkel LM, Angelini C. Cross-reactive protein in Duchenne muscle. Lancet. 1989 Nov 18;2(8673):1211–1212. [PubMed]
  • Holmes E, Foxall PJ, Nicholson JK, Neild GH, Brown SM, Beddell CR, Sweatman BC, Rahr E, Lindon JC, Spraul M, et al. Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem. 1994 Aug 1;220(2):284–296. [PubMed]
  • Hu Jian Zhi, Rommereim Donald N, Wind Robert A. High-resolution 1H NMR spectroscopy in rat liver using magic angle turning at a 1 Hz spinning rate. Magn Reson Med. 2002 May;47(5):829–836. [PubMed]
  • Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992 Jan;72(1):101–163. [PubMed]
  • Kacser H, Burns JA. The control of flux. Symp Soc Exp Biol. 1973;27:65–104. [PubMed]
  • Kato T, Nishina M, Matsushita K, Hori E, Akaboshi S, Takashima S. Increased cerebral choline-compounds in Duchenne muscular dystrophy. Neuroreport. 1997 Apr 14;8(6):1435–1437. [PubMed]
  • Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 1994 Nov;8(3):221–228. [PubMed]
  • Kell Douglas B. Metabolomics and machine learning: explanatory analysis of complex metabolome data using genetic programming to produce simple, robust rules. Mol Biol Rep. 2002;29(1-2):237–241. [PubMed]
  • Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci. 1993 Jun;116(2):201–206. [PubMed]
  • Keun Hector C, Beckonert Olaf, Griffin Julian L, Richter Christian, Moskau Detlef, Lindon John C, Nicholson Jeremy K. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem. 2002 Sep 1;74(17):4588–4593. [PubMed]
  • Khurana TS, Watkins SC, Chafey P, Chelly J, Tomé FM, Fardeau M, Kaplan JC, Kunkel LM. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord. 1991;1(3):185–194. [PubMed]
  • Klose Joachim, Nock Christina, Herrmann Marion, Stühler Kai, Marcus Katrin, Blüggel Martin, Krause Eberhard, Schalkwyk Leonard C, Rastan Sohaila, Brown Steve D M, et al. Genetic analysis of the mouse brain proteome. Nat Genet. 2002 Apr;30(4):385–393. [PubMed]
  • Kose F, Weckwerth W, Linke T, Fiehn O. Visualizing plant metabolomic correlation networks using clique-metabolite matrices. Bioinformatics. 2001 Dec;17(12):1198–1208. [PubMed]
  • Krag TO, Gyrd-Hansen M, Khurana TS. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. Acta Physiol Scand. 2001 Mar;171(3):349–358. [PubMed]
  • Lederfein D, Levy Z, Augier N, Mornet D, Morris G, Fuchs O, Yaffe D, Nudel U. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5346–5350. [PMC free article] [PubMed]
  • Lindon John C, Nicholson Jeremy K, Holmes Elaine, Antti Henrik, Bollard Mary E, Keun Hector, Beckonert Olaf, Ebbels Timothy M, Reily Michael D, Robertson Donald, et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol. 2003 Mar 15;187(3):137–146. [PubMed]
  • McIntosh LM, Garrett KL, Megeney L, Rudnicki MA, Anderson JE. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles. Anat Rec. 1998 Oct;252(2):311–324. [PubMed]
  • McIntosh LM, Baker RE, Anderson JE. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol. 1998;76(2-3):532–541. [PubMed]
  • Mole SE, Mitchison HM, Munroe PB. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. Hum Mutat. 1999;14(3):199–215. [PubMed]
  • Mokhtarian A, Decrouy A, Chinet A, Even PC. Components of energy expenditure in the mdx mouse model of Duchenne muscular dystrophy. Pflugers Arch. 1996 Feb;431(4):527–532. [PubMed]
  • Moolenaar SH, Engelke UFH, Wevers RA. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem. 2003 Jan;40(Pt 1):16–24. [PubMed]
  • Nicholson JK, Higham DP, Timbrell JA, Sadler PJ. Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol Pharmacol. 1989 Sep;36(3):398–404. [PubMed]
  • Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999 Nov;29(11):1181–1189. [PubMed]
  • Nicholson Jeremy K, Connelly John, Lindon John C, Holmes Elaine. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002 Feb;1(2):153–161. [PubMed]
  • Nicholson Jeremy K, Wilson Ian D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003 Aug;2(8):668–676. [PubMed]
  • Nudel U, Zuk D, Einat P, Zeelon E, Levy Z, Neuman S, Yaffe D. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature. 1989 Jan 5;337(6202):76–78. [PubMed]
  • Oliver SG. From DNA sequence to biological function: the new "Voyage of the Beagle'. Biochem Soc Trans. 1996 Feb;24(1):291–292. [PubMed]
  • Oliver Stephen G. Functional genomics: lessons from yeast. Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29;357(1417):17–23. [PMC free article] [PubMed]
  • Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998 Sep;16(9):373–378. [PubMed]
  • Pichersky E, Gang DR. Genetics and biochemistry of secondary metabolites in plants: an evolutionary perspective. Trends Plant Sci. 2000 Oct;5(10):439–445. [PubMed]
  • Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh MC, Berden JA, Brindle KM, Kell DB, Rowland JJ, et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol. 2001 Jan;19(1):45–50. [PubMed]
  • Rae C, Scott RB, Thompson CH, Dixon RM, Dumughn I, Kemp GJ, Male A, Pike M, Styles P, Radda GK. Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study. J Neurol Sci. 1998 Oct 8;160(2):148–157. [PubMed]
  • Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási AL. Hierarchical organization of modularity in metabolic networks. Science. 2002 Aug 30;297(5586):1551–1555. [PubMed]
  • Robertson DG, Reily MD, Sigler RE, Wells DF, Paterson DA, Braden TK. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci. 2000 Oct;57(2):326–337. [PubMed]
  • Roessner U, Wagner C, Kopka J, Trethewey RN, Willmitzer L. Technical advance: simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry. Plant J. 2000 Jul;23(1):131–142. [PubMed]
  • Rosenberg RN. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov Disord. 1992;7(3):193–203. [PubMed]
  • Rybakova Inna N, Patel Jitandrakumar R, Davies Kay E, Yurchenco Peter D, Ervasti James M. Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell. 2002 May;13(5):1512–1521. [PMC free article] [PubMed]
  • Schoolnik Gary K. Microarray analysis of bacterial pathogenicity. Adv Microb Physiol. 2002;46:1–45. [PubMed]
  • Shockcor John P, Holmes Elaine. Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem. 2002 Jan;2(1):35–51. [PubMed]
  • Smith LL. Key challenges for toxicologists in the 21st century. Trends Pharmacol Sci. 2001 Jun;22(6):281–285. [PubMed]
  • Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. NMR Biomed. 2001 Jun;14(4):271–277. [PubMed]
  • Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. III. A generalized procedure for determination of lineshape variations. J Magn Reson. 2002 Feb;154(2):163–175. [PubMed]
  • Sze DY, Jardetzky O. High-resolution proton NMR studies of lymphocyte extracts. Immunomethods. 1994 Apr;4(2):113–126. [PubMed]
  • Takiyama Y, Oyanagi S, Kawashima S, Sakamoto H, Saito K, Yoshida M, Tsuji S, Mizuno Y, Nishizawa M. A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology. 1994 Jul;44(7):1302–1308. [PubMed]
  • Tate AR, Crabb S, Griffiths JR, Howells SL, Mazucco RA, Rodrigues LM, Watson D. Lipid metabolite peaks in pattern recognition analysis of tumour in vivo MR spectra. Anticancer Res. 1996 May-Jun;16(3B):1575–1579. [PubMed]
  • Teusink B, Walsh MC, van Dam K, Westerhoff HV. The danger of metabolic pathways with turbo design. Trends Biochem Sci. 1998 May;23(5):162–169. [PubMed]
  • Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med. 1998 Dec;4(12):1441–1444. [PubMed]
  • Tracey I, Dunn JF, Radda GK. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy. Brain. 1996 Jun;119(Pt 3):1039–1044. [PubMed]
  • Tweeddale H, Notley-McRobb L, Ferenci T. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis. J Bacteriol. 1998 Oct;180(19):5109–5116. [PMC free article] [PubMed]
  • Valafar Faramarz. Pattern recognition techniques in microarray data analysis: a survey. Ann N Y Acad Sci. 2002 Dec;980:41–64. [PubMed]
  • Vance JE, Stone SJ, Faust JR. Abnormalities in mitochondria-associated membranes and phospholipid biosynthetic enzymes in the mnd/mnd mouse model of neuronal ceroid lipofuscinosis. Biochim Biophys Acta. 1997 Feb 18;1344(3):286–299. [PubMed]
  • Waters NJ, Holmes E, Williams A, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem Res Toxicol. 2001 Oct;14(10):1401–1412. [PubMed]
  • Waters Nigel J, Holmes Elaine, Waterfield Catherine J, Farrant R Duncan, Nicholson Jeremy K. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochem Pharmacol. 2002 Jul 1;64(1):67–77. [PubMed]
  • Weybright P, Millis K, Campbell N, Cory DG, Singer S. Gradient, high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells. Magn Reson Med. 1998 Mar;39(3):337–345. [PubMed]
  • Wind RA, Hu JZ, Rommereim DN. High-resolution (1)H NMR spectroscopy in organs and tissues using slow magic angle spinning. Magn Reson Med. 2001 Aug;46(2):213–218. [PubMed]
  • Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999 Aug 6;285(5429):901–906. [PubMed]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...